Rotavirus vaccines: considerations for successful implementation in Europe

Pierre Van Damme, Marie Van der Wielen, Filippo Ansaldi, Daniel Desgrandchamps, Javier Diez Domingo, Francisco Gimenez Sanchez, Jim Gray, Martin Haditsch, Kari Johansen, Paula Lorgelly, Mathie Lorrot, Nathalie Parez, Volkmar Reschke, Markus Rose

Research output: Contribution to journalArticlepeer-review


A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent severe rotavirus gastroenteritis, and that European countries should consider implementing rotavirus vaccination in their routine immunisation programmes. The main barrier to the implementation of rotavirus vaccination in Europe is a general lack of awareness of stakeholders, policymakers, health-care professionals, and parents about rotavirus disease and the advantages of vaccination. Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe.

Original languageEnglish
Pages (from-to)805-812
Number of pages8
JournalThe Lancet Infectious Diseases
Issue number12
Publication statusPublished - Dec 2006

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Rotavirus vaccines: considerations for successful implementation in Europe'. Together they form a unique fingerprint.

Cite this